STRS Ohio’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

STRS Ohio’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,300	Closed	-$192K	–	2341
2020 Q3	$192K	Hold	14,300	–	–	﹤0.01%	1687
2020 Q2	$605K	Sell	14,300 -4,800	-25%	-$155K	﹤0.01%	1174
2020 Q1	$527K	Sell	19,100 -1,800	-9%	-$52.5K	﹤0.01%	1085
2019 Q4	$678K	Sell	20,900 -600	-3%	-$18.6K	﹤0.01%	1209
2019 Q3	$559K	Buy	21,500 +6,700	+45%	+$224K	﹤0.01%	1199
2019 Q2	$543K	Buy	14,800 +12,900	+679%	+$309K	﹤0.01%	1256
2019 Q1	$42K	Hold	1,900	–	–	﹤0.01%	1910
2018 Q4	$26K	Hold	1,900	–	–	﹤0.01%	1969
2018 Q3	$36K	Hold	1,900	–	–	﹤0.01%	1988
2018 Q2	$41K	Hold	1,900	–	–	﹤0.01%	2008
2018 Q1	$40K	Buy	+1,900	New	+$44.8K	﹤0.01%	1768

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

STRS Ohio's ODT Position: Q4 2020 in Review

STRS Ohio sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2020, closing a stake of 14,300 shares — an estimated $192K sold.

STRS Ohio first reported a position in ODT in Q1 2018 and held it in 11 quarters. The position peaked at $678K in Q4 2019. 94 funds tracked by Wall St. Rank hold ODT as of Q4 2020.

STRS Ohio reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 14,300 Odonate Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $192K.
STRS Ohio first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 11 quarters.
STRS Ohio's Odonate Therapeutics, Inc. Common Stock position peaked at $678K in Q4 2019.
94 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.